Heart attack survivors: could a new shot clear your clogged arteries?
NCT ID NCT06372925
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This study tests if a drug called inclisiran can reduce fatty plaque buildup in the arteries of people who recently had a heart attack and have high cholesterol. About 318 adults will receive either inclisiran or standard care, and doctors will use special imaging to measure plaque changes over one year. The goal is to see if this treatment can help control heart disease and prevent future problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novartis Investigative Site
Hefei, Anhui, 230001, China
-
Novartis Investigative Site
Fuzhou, Fujian, 350001, China
-
Novartis Investigative Site
Guangzhou, Guangdong, 510000, China
-
Novartis Investigative Site
Guangzhou, Guangdong, 510080, China
-
Novartis Investigative Site
Shenzhen, Guangdong, 518000, China
-
Novartis Investigative Site
Zunyi, Guizhou, 563000, China
-
Novartis Investigative Site
Harbin, Heilongjiang, 150086, China
-
Novartis Investigative Site
Zhengzhou, Henan, 450003, China
-
Novartis Investigative Site
Wuhan, Hubei, 430060, China
-
Novartis Investigative Site
Nanchang, Jiangxi, 330006, China
-
Novartis Investigative Site
Changchun, Jilin, 130033, China
-
Novartis Investigative Site
Dalian, Liaoning, 116023, China
-
Novartis Investigative Site
Jining, Shandong, 272000, China
-
Novartis Investigative Site
Xian, Shanxi, 710061, China
-
Novartis Investigative Site
Chengdu, Sichuan, 610072, China
-
Novartis Investigative Site
Wenzhou, Zhejiang, 325027, China
-
Novartis Investigative Site
Beijing, 101149, China
-
Novartis Investigative Site
Lanzhou, 730000, China
-
Novartis Investigative Site
Tianjin, 300000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which strategy wins for heart attack patients with multiple blocked arteries?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Could a purified fish oil calm the 'hot' plaques that trigger heart attacks?
- Can a quick shot stop a heart attack in its tracks?
- A sharper eye on the heart: new blood test aims to spot heart attacks faster
- Can a Stick-On AI patch replace wires for heart monitoring after surgery?